{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:51:49Z","timestamp":1788360709586,"version":"build-2803163510"},"reference-count":95,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lysosomal storage disorders (LSDs) are predominantly very rare recessive autosomal neurodegenerative diseases.Sphingolipidoses, a sub-group of LSDs, result from defects in lysosomal enzymes involved in sphingolipid catabolism, and feature disrupted storage systems which trigger complex pathogenic cascades with other organelles collaterally affected. This process leads to cell dysfunction and death, particularly in the central nervous system. One valuable approach to gaining insights into the global impact of lysosomal dysfunction is through metabolomics, which represents a discovery tool for investigating disease-induced modifications in the patterns of large numbers of simultaneously-analysed metabolites, which also features the identification of biomarkers Here, the scope and applications of metabolomics strategies to the investigation of sphingolipidoses is explored in order to facilitate our understanding of the biomolecular basis of these conditions. This review therefore surveys the benefits of applying \u2019state-of-the-art\u2019 metabolomics strategies, both univariate and multivariate, to sphingolipidoses, particularly Niemann-Pick type C disease. Relevant limitations of these techniques are also discussed, along with the latest advances and developments. We conclude that metabolomics strategies are highly valuable, distinctive bioanalytical techniques for probing LSDs, most especially for the detection and validation of potential biomarkers. They also show much promise for monitoring disease progression and the evaluation of therapeutic strategies and targets.<\/jats:p>","DOI":"10.3390\/ijms21072533","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T06:10:28Z","timestamp":1586153428000},"page":"2533","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolomic Studies of Lipid Storage Disorders, with Special Reference to Niemann-Pick Type C Disease: A Critical Review with Future Perspectives"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-8979","authenticated-orcid":false,"given":"Benita Claire","family":"Percival","sequence":"first","affiliation":[{"name":"Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Gibson","sequence":"additional","affiliation":[{"name":"Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-2246","authenticated-orcid":false,"given":"Philippe B.","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Animal, Rural and Environmental Sciences, Brackenhurst Campus, Nottingham Trent University, Southwell NG25 0QF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7614-0403","authenticated-orcid":false,"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Oxford, Mansfield Rd, Oxford OX1 3QT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-3734","authenticated-orcid":false,"given":"Martin","family":"Grootveld","sequence":"additional","affiliation":[{"name":"Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature13476","article-title":"Sphingolipid lysosomal storage disorders","volume":"510","author":"Platt","year":"2014","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2019.08.038","article-title":"Structural Insight into Eukaryotic Sterol Transport through Niemann-Pick Type C Proteins","volume":"3","author":"Winkler","year":"2019","journal-title":"Cell"},{"key":"ref_3","first-page":"1","article-title":"Lysosomal Storage Diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_4","first-page":"294","article-title":"Metabolomics for the masses: The future of metabolomics in a personalized world","volume":"3","author":"Trivedi","year":"2017","journal-title":"New Horizons Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ctrv.2018.04.012","article-title":"Metabolomics in breast cancer: A decade in review","volume":"67","author":"McCartney","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbcan.2018.04.009","article-title":"Applications of metabolomics to study cancer metabolism","volume":"1870","author":"Kaushik","year":"2018","journal-title":"Biochim Biophys Acta - Rev Cancer."},{"key":"ref_7","first-page":"27","article-title":"Emerging candidate biomarkers for Parkinson\u2019s disease: A review","volume":"5","author":"Saracchi","year":"2014","journal-title":"Aging Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Grootveld, M. (2014). Metabolic Profiling: Disease and Xenobiotics (Issues in Toxicology), Royal Society of Chemistry. [1st ed.].","DOI":"10.1039\/9781849735162"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1194\/jlr.M040618","article-title":"Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling","volume":"54","author":"Fan","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymgmr.2018.03.005","article-title":"Elevation of plasma lysosphingomyelin-509 and urinary bile acid metabolite in Niemann-Pick disease type C-affected individuals","volume":"15","author":"Mashima","year":"2018","journal-title":"Mol Genet Metab Reports."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cca.2014.07.010","article-title":"A new simple and rapid LC-ESI-MS\/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease","volume":"437","author":"Boenzi","year":"2014","journal-title":"Clin. Chim. Acta."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinbiochem.2015.03.007","article-title":"LC-MS\/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases","volume":"48","author":"Klinke","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0004563214568871","article-title":"Focused metabolomics using liquid chromatography\/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann\u2013Pick disease type C and 3\u03b2-hydroxysteroid dehydrogenase deficiency","volume":"52","author":"Maekawa","year":"2015","journal-title":"Ann Clin Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease","volume":"2","author":"Porter","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1021\/acs.jproteome.6b00238","article-title":"1H NMR-Linked Metabolomics Analysis of Liver from a Mouse Model of NP-C1 Disease","volume":"15","author":"Nicoli","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06264-2","article-title":"NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls","volume":"7","author":"Probert","year":"2017","journal-title":"Sci Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.steroids.2013.05.017","article-title":"LC\/ESI-MS\/MS analysis of urinary 3\u03b2-sulfooxy-7\u03b2-N- acetylglucosaminyl- 5-cholen-24-oic acid and its amides: New biomarkers for the detection of Niemann-Pick type C disease","volume":"78","author":"Maekawa","year":"2013","journal-title":"Steroids"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cca.2019.03.1610","article-title":"Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann\u2013Pick disease type C","volume":"494","author":"Maekawa","year":"2019","journal-title":"Clin Chim Acta."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1194\/jlr.M093971","article-title":"Development of a Simultaneous Analytical Method for Five Conjugated Cholesterol Metabolites in Urine and Investigation of Their Performance as Diagnostic Markers for Niemann-Pick Disease Type C","volume":"60","author":"Maekawa","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/2213235X02666141112215616","article-title":"1H NMR-Linked Urinary Metabolic Profiling of Niemann-Pick Class C1 (NPC1) Disease: Identification of Potential New Biomarkers using Correlated Component Regression (CCR) and Genetic Algorithm (GA) Analysis Strategies","volume":"2","author":"Vruchte","year":"2014","journal-title":"Curr. Metabol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S0053","DOI":"10.5702\/massspectrometry.S0053","article-title":"Identification of Two Sulfated Cholesterol Metabolites Found in the Urine of a Patient with Niemann\u2013Pick Disease Type C as Novel Candidate Diagnostic Markers","volume":"5","author":"Maekawa","year":"2016","journal-title":"Mass Spectrom."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Welford, R.W.D., Garzotti, M., Louren\u00e7o, C.M., Mengel, E., Marquardt, T., Reunert, J., Amaroui, Y., Kolb, S.A., Morand, O., and Groenen, P. (2014). Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for niemann-pick disease type C in a retrospective study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114669"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1194\/jlr.D044024","article-title":"Determination of 7-ketocholesterol in plasma by lc-ms for rapid diagnosis of acid smase-deficient niemann-pick disease","volume":"55","author":"Lin","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/1873-3468.12196","article-title":"Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease","volume":"590","author":"Mazzacuva","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1194\/jlr.M060343","article-title":"Cholestane-3\u03b2,5\u03b1,6\u03b2-triol: High levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency","volume":"56","author":"Pajares","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s00216-016-9318-1","article-title":"Variations in plasma and urinary lipids in response to enzyme replacement therapy for Fabry disease patients by nanoflow UPLC-ESI-MS\/MS","volume":"408","author":"Byeon","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Boutin","year":"2012","journal-title":"Anal. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2019.10.005","article-title":"The clinical utility of total concentration of urinary globotriaosylsphingosine plus its analogues in the diagnosis of fabry disease","volume":"500","author":"Alharbi","year":"2020","journal-title":"Clin Chim Acta."},{"key":"ref_32","first-page":"3733","article-title":"Clinical significance of plasma globotriaosylsphingosine levels in chinese patients with fabry disease","volume":"15","author":"Ouyang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13361-014-1060-3","article-title":"Metabolomic discovery of novel urinary galabiosylceramide\u2208analogs as Fabry disease biomarkers","volume":"26","author":"Boutin","year":"2015","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2014.08.002","article-title":"Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry","volume":"438","author":"Blais","year":"2014","journal-title":"Clin Chim Acta."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sueoka, H., Ichihara, J., Tsukimura, T., Togawa, T., and Sakuraba, H. (2015). Nano-LC-MS\/MS for quantification of lyso-Gb3 and its analogues reveals a useful biomarker for fabry disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127048"},{"key":"ref_36","first-page":"128","article-title":"Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry","volume":"883\u2013884","author":"Tholey","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1021\/ac404000d","article-title":"Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb 3-related analogues in fabry disease","volume":"86","author":"Boutin","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cca.2015.11.018","article-title":"Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients","volume":"452","author":"Abaoui","year":"2016","journal-title":"Clin. Chim. Acta."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2013","journal-title":"Clin Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.bbadis.2019.07.005","article-title":"Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients","volume":"1865","author":"Heywood","year":"2019","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Basis Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1570-0232(02)00177-0","article-title":"Application of delayed extraction-matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in pericardial fluid, peritoneal fluid and serum from Gaucher disease patients","volume":"776","author":"Fujiwaki","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbalip.2007.11.004","article-title":"Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: Correlations with disease severity and response to therapeutic intervention","volume":"1781","author":"Groener","year":"2008","journal-title":"Biochim. Biophys. Acta \u2013 Mol. Cell. Biol. Lipids."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rolfs, A., Giese, A.-K., Grittner, U., Mascher, D., Elstein, D., Zimran, A., B\u00f6ttcher, T., Lukas, J., H\u00fcbner, R., and G\u00f6lnitz, U. (2013). Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079732"},{"key":"ref_46","first-page":"e118","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: Relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hurvitz, N., Dinur, T., Cohen-Becker, M., Cozma, C., Hovakimyan, M., Opperman, S., Demuth, L., Rolfs, A., Abramov, A., and Zimran, A. (2019). Glucosylsphingosine (Lyso-gb1) as a biomarker for monitoring treated and untreated children with gaucher disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123033"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jnr.23789","article-title":"Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease","volume":"94","author":"Weinstock","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","article-title":"Psychosine, a marker of Krabbe phenotype and treatment effect","volume":"121","author":"Escolar","year":"2017","journal-title":"Mol Genet Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-015-9822-z","article-title":"Measurement of psychosine in dried blood spots \u2014 a possible improvement to newborn screening programs for Krabbe disease","volume":"38","author":"Turgeon","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1373\/clinchem.2003.020214","article-title":"N-acetylated metabolites in urine: Proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism","volume":"50","author":"Engelke","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ajpath.2016.02.012","article-title":"Presymptomatic Alterations in Amino Acid Metabolism and DNA Methylation in the Cerebellum of a Murine Model of Niemann-Pick Type C Disease","volume":"186","author":"Kennedy","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1194\/jlr.D058487","article-title":"A validated LC-MS\/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid","volume":"56","author":"Sidhu","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1093\/hmg\/ddu331","article-title":"Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1)","volume":"23","author":"Tortelli","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/heartjnl-2016-310914","article-title":"Plasma 7-ketocholesterol levels and the risk of incident cardiovascular events","volume":"103","author":"Wang","year":"2017","journal-title":"Heart"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.RA119000157","article-title":"N -acyl- O -phosphocholineserines: Structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease","volume":"60","author":"Sidhu","year":"2019","journal-title":"J Lipid Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/jcp.29137","article-title":"Accumulation of sphingomyelin in Niemann-Pick disease type C cells disrupts Rab9-dependent vesicular trafficking of cholesterol","volume":"235","author":"Wanikawa","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpba.2015.08.011","article-title":"Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state 1H NMR studies","volume":"117","author":"Probert","year":"2016","journal-title":"J. Pharm. Biomed Anal."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2018.06.051","article-title":"Application of a simple methodology to analyze Hydroxypropyl-\u03b2-Cyclodextrin in urine using HPLC\u2013LS in early Niemann\u2013Pick disease type C patient","volume":"1093\u20131094","author":"Matencio","year":"2018","journal-title":"J Chromatogr B."},{"key":"ref_62","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 301500}. Available online: https:\/\/omim.org\/."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.aca.2018.02.022","article-title":"Analysis of globotriaosylceramide (Gb3) isoforms\/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography\/tandem mass spectrometry","volume":"1015","author":"Toupin","year":"2018","journal-title":"Anal Chim Acta."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","article-title":"The future of NMR-based metabolomics","volume":"43","author":"Markley","year":"2017","journal-title":"Curr Opin Biotechnol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","article-title":"Urinary lipid profiling for the identification of fabry hemizygotes and heterozygotes","volume":"51","author":"Fuller","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_66","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 230900}. Available online: https:\/\/omim.org\/."},{"key":"ref_67","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 231000}. Available online: https:\/\/omim.org\/."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2015.07.026","article-title":"Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool","volume":"450","author":"Fuller","year":"2015","journal-title":"Clin Chim Acta."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s12010-012-9891-5","article-title":"Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment","volume":"168","author":"Zhang","year":"2012","journal-title":"Appl. Biochem Biotechnol."},{"key":"ref_70","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 245200}. Available online: https:\/\/omim.org\/."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymgme.2011.10.010","article-title":"Krabbe disease: Clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards","volume":"105","author":"Puckett","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_72","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 230500}. Available online: https:\/\/omim.org\/."},{"key":"ref_73","unstructured":"Johns Hopkins University, Baltimore, MD (2020, March 26). Online Mendelian Inheritance in Man, OMIM\u00ae. MIM Number: {OMIM 268800}. Available online: https:\/\/omim.org\/."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2018.09.005","article-title":"Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease","volume":"126","author":"Ou","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1194\/jlr.D800038-JLR200","article-title":"Targeted analysis of ganglioside and sulfatide molecular species by LC\/ESI-MS\/MS with theoretically expanded multiple reaction monitoring","volume":"49","author":"Ikeda","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2013.11.025","article-title":"Rapid and sensitive LC-ESI-MS of gangliosides","volume":"947\u2013948","author":"Garcia","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clinbiochem.2007.12.026","article-title":"Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry","volume":"41","author":"Gu","year":"2008","journal-title":"Clin Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymgme.2014.11.015","article-title":"Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses","volume":"114","author":"Utz","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/096721090201000501","article-title":"The effect of age on serum creatinine levels in an aging population: Relevance to vascular surgery","volume":"10","author":"Tiao","year":"2002","journal-title":"Cardiovasc Surg."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: The human metabolome database for 2018","volume":"4","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0135437","article-title":"Reliability of serum metabolites over a two-year period: A targeted metabolomic approach in fasting and non-fasting samples from EPIC","volume":"10","author":"Carayol","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: A new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_83","unstructured":"Lindon, J.C., Nicholson, J.K., and Holmes, E. (2011). The Handbook of Metabolomics, Elsevier."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","article-title":"Beyond the Paradigm: Combining Mass Spectrometry and Nuclear Magnetic Resonance for Metabolomics","volume":"100","author":"Marshall","year":"2017","journal-title":"Prog. Nucl. Magn. Reason. Spectrosc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","article-title":"Reflections on univariate and multivariate analysis of metabolomics data","volume":"10","author":"Saccenti","year":"2014","journal-title":"Metabolomics."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0--making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/bib\/bbu052","article-title":"Sample size calculation in metabolic phenotyping studies","volume":"16","author":"Billoir","year":"2014","journal-title":"Brief Bioinform."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Nyamundanda, G., Gormley, I.C., Fan, Y., Gallagher, W.M., and Brennan, L. (2013). MetSizeR: Selecting the optimal sample size for metabolomic studies using an analysis-based approach. BMC Bioinformatics., 14.","DOI":"10.1186\/1471-2105-14-338"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"van Iterson, M., \u2019t Hoen, P.A.C., Pedotti, P., Hooiveld, G.J., den Dunnen, J.T., van Ommen, G.J., Boer, J.M., and Menezes, R.X. (2009). Relative power and sample size analysis on gene expression profiling data. BMC Genomics., 10.","DOI":"10.1186\/1471-2164-10-439"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/metabo2040775","article-title":"guideline to univariate statistical analysis for LC\/MS-based untargeted metabolomics-derived data","volume":"2","author":"Vinaixa","year":"2012","journal-title":"Metabolites."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trsl.2017.06.005","article-title":"The future perspective: Metabolomics in laboratory medicine for inborn errors of metabolism","volume":"189","author":"Sandlers","year":"2017","journal-title":"Transl Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2016.10.002","article-title":"Emerging therapies for neuropathic lysosomal storage disorders","volume":"152","author":"Kelly","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.01.112","article-title":"1H NMR analysis as a diagnostic probe for human saliva","volume":"329","author":"Grootveld","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Percival, B.C., Grootveld, M., Gibson, M., Osman, Y., Molinari, M., Jafari, F., Sahota, T., Martin, M., Casanova, F., and Mather, M.L. (2019). Low-field, benchtop NMR spectroscopy as a potential tool for point-of-care diagnostics of metabolic conditions: Validation, protocols and computational models. High-Throughput, 8.","DOI":"10.20944\/preprints201810.0089.v2"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.07.015","article-title":"Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: In utero indicators of lysosomal storage diseases","volume":"83","author":"Ramsay","year":"2004","journal-title":"Mol. Genet. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/7\/2533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:15:47Z","timestamp":1760174147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/7\/2533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,5]]},"references-count":95,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21072533"],"URL":"https:\/\/doi.org\/10.3390\/ijms21072533","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,5]]}}}